Evidence map›Paper›PMID 41099192›Full record

ArticleHuman vaccines & immunotherapeutics2025

Recombinant

Yuxiao Chang, Huanhuan Ning, Xuan Liang, Yanzhi Lu, Jian Kang, Xue Li, Shangqi Liu, Leran Hao, Yanling Ma, Fanglin Zhang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Antigen 85B ofVaccines · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuxiao ChangDepartment of Microbiology and Pathogen Biology, The Forth Military Medical University, Xi'an, China.
Huanhuan NingDepartment of Microbiology and Pathogen Biology, The Forth Military Medical University, Xi'an, China.
Xuan LiangDepartment of Microbiology and Pathogen Biology, The Forth Military Medical University, Xi'an, China.
Yanzhi LuDepartment of Microbiology and Pathogen Biology, The Forth Military Medical University, Xi'an, China.
Jian KangDepartment of Microbiology and Pathogen Biology, The Forth Military Medical University, Xi'an, China.
Xue LiDepartment of Microbiology and Pathogen Biology, The Forth Military Medical University, Xi'an, China.
Shangqi LiuDepartment of Microbiology and Pathogen Biology, The Forth Military Medical University, Xi'an, China.
Leran HaoDepartment of Microbiology and Pathogen Biology, The Forth Military Medical University, Xi'an, China.
Yanling MaCollege of Life Sciences, Northwest University, Xi'an, China.
Fanglin ZhangDepartment of Microbiology and Pathogen Biology, The Forth Military Medical University, Xi'an, China.
Yinlan BaiDepartment of Microbiology and Pathogen Biology, The Forth Military Medical University, Xi'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis is a serious, chronic infectious disease worldwide, primarily caused by

Indexed as

AcyltransferasesAntigens, BacterialBacterial ProteinsImmunotherapyMycobacterium smegmatisTuberculosisTuberculosis VaccinesAnimalsAntibodies, BacterialBacterial LoadCD8-Positive T-LymphocytesCytokinesDisease Models, AnimalFemaleImmunity, CellularLungAcyltransferasesAntibodies, Bacterialantigen 85B, Mycobacterium tuberculosisAntigens, BacterialBacterial ProteinsCytokinesTuberculosis VaccinesVaccines, SyntheticAg85BMycobacterium smegmatisMycobacterium tuberculosistherapeutic vaccineTuberculosis

Identifiers

PMID41099192
PMCPMC12533959

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.